Hallmarks for senescence in carcinogenesis: novel signaling players

M Cecilia Caino1, John Meshki, Marcelo G Kazanietz

  • 1Department of Pharmacology, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA.

Insights

Cellular senescence, a tumor suppressor mechanism, halts cancer cell proliferation. Novel research reveals protein kinase C (PKC) activation can induce senescence, offering new therapeutic strategies against cancer.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Cellular senescence is a critical anti-cancer mechanism.
  • Tumor suppressor genes like p53 and pRb control senescence, preventing cancer progression.
  • Senescence is triggered by DNA damage, oncogenic signals, or excessive mitogenic input.

Purpose of the Study:

  • To explore novel signaling pathways involved in cellular senescence.
  • To investigate the role of protein kinase C (PKC) isozymes in modulating senescence phenotypes.
  • To assess the potential of PKC activators in cancer therapy.

Main Methods:

  • Review of emerging evidence in cellular and in vivo models.
  • Analysis of signaling players including PML, CK2, Bcl-2, PI3K effectors, Rho small GTPases, and cytokines.
  • Examination of phorbol ester-induced senescence in cancer cells.

Main Results:

  • Identified diverse signaling molecules contributing to senescence.
  • Demonstrated that phorbol esters, PKC activators, can induce senescence in various cancer cells.
  • Highlighted the complex interplay between senescence pathways.

Conclusions:

  • Cellular senescence is a multifaceted process involving numerous signaling pathways.
  • PKC isozymes are significant modulators of senescence.
  • Targeting senescence pathways, particularly via PKC activation, holds promise for novel cancer therapies.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...